BlackRock
BCAB icon

BlackRock’s BioAtla BCAB Stock Holding History

BlackRock’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.8K Sell
9,616
-3
-0% -$13 ﹤0.01% 5234
2026
Q1 		$77.4K Hold
9,619
– – ﹤0.01% 5020
2025
Q4 		$273K Hold
9,619
– – ﹤0.01% 4641
2025
Q3 		$331K Hold
9,619
– – ﹤0.01% 4561
2025
Q2 		$190K Sell
9,619
-2,259
-19% -$45.8K ﹤0.01% 4681
2025
Q1 		$206K Sell
11,878
-890
-7% -$19K ﹤0.01% 4596
2024
Q4 		$377K Buy
12,768
+863
+7% +$72.4K ﹤0.01% 4493
2024
Q3 		$1.05M Sell
11,905
-3,926
-25% -$329K ﹤0.01% 4163
2024
Q2 		$1.08M Sell
15,831
-39,763
-72% -$4.73M ﹤0.01% 4156
2024
Q1 		$9.56M Sell
55,594
-2,086
-4% -$259K ﹤0.01% 3372
2023
Q4 		$7.09M Sell
57,680
-4,588
-7% -$398K ﹤0.01% 3550
2023
Q3 		$5.29M Sell
62,268
-1,708
-3% -$218K ﹤0.01% 3636
2023
Q2 		$9.6M Buy
63,976
+44,306
+225% +$7.62M ﹤0.01% 3435
2023
Q1 		$2.64M Sell
19,670
-634
-3% -$114K ﹤0.01% 3923
2022
Q4 		$8.38M Buy
20,304
+4,271
+27% +$1.77M ﹤0.01% 3479
2022
Q3 		$6.17M Buy
16,033
+2,281
+17% +$747K ﹤0.01% 3661
2022
Q2 		$1.96M Sell
13,752
-18,133
-57% -$2.89M ﹤0.01% 4256
2022
Q1 		$7.97M Buy
31,885
+167
+0.5% +$69.9K ﹤0.01% 3707
2021
Q4 		$31.1M Buy
31,718
+6,304
+25% +$8.06M ﹤0.01% 2997
2021
Q3 		$37.4M Buy
25,414
+3,578
+16% +$6.97M ﹤0.01% 2854
2021
Q2 		$46.3M Buy
21,836
+2,489
+13% +$5.62M ﹤0.01% 2752
2021
Q1 		$49.2M Buy
19,347
+16,410
+559% +$42.1M ﹤0.01% 2620
2020
Q4 		$4.99M Buy
+2,937
New +$4.91M ﹤0.01% 3708

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's BCAB Position: Q2 2026 in Review

BlackRock reduced its BioAtla (BCAB) stake by 0.03% in Q2 2026, selling an estimated $13 and leaving 9,616 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5234.

BlackRock first reported a position in BCAB in Q4 2020 and has held it in 23 quarters since. The position peaked at $49.2M in Q1 2021. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • BlackRock held 9,616 shares of BioAtla worth $39.8K as of Q2 2026.
  • BlackRock sold 3 BioAtla shares in Q2 2026, an estimated $13.
  • BioAtla made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5234 holding.
  • BlackRock first reported a position in BioAtla in Q4 2020 and has held it in 23 quarters since.
  • BlackRock's BioAtla position peaked at $49.2M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.